Aberrant expression of HLA-B*3565Q is associated with a disrupted disulfide bond

Immunogenetics

Volumn 58, Issue 11, 2006, Pages 929-931

  Elsner, Holger Andreas ^a   Horn, Peter A ^b   Schoenemann, Constanze ^c   Altermann, Wolfgang W ^d   Blasczyk, Rainer ^b  

^a Labor Dres Fenner and Partner   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Disulfide bond; HLA structure; HLA B*3565Q; SBT; Sequence

Indexed keywords

HLA B35 ANTIGEN;

ALLELE; ARTICLE; CYTOTOXICITY; DISEASE ASSOCIATION; DISULFIDE BOND; EXON; GENE EXPRESSION; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; LYMPHOBLASTOID CELL; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY; SUBSTITUTION REACTION;

ALLELES; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BASE SEQUENCE; CYSTEINE; DISULFIDES; EXONS; HLA-B ANTIGENS; HUMANS; MOLECULAR SEQUENCE DATA; TRYPTOPHAN;

VERTEBRATA;

EID: 33751369036     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00251-006-0158-6     Document Type: Article

References (13)

1. Elsner HA, Blasczyk R (2004) Immunogenetics of HLA null alleles: implications for blood stem cell transplantation. Tissue Antigens 64:687-695
2. Grossberger D, Parham P (1992) Reptilian class I major histocompatibility complex genes reveal conserved elements in class I structure. Immunogenetics 36:166-174
3. Jordan BR, Lemonnier FA, Caillol DH, Trucy J (1983) Transformation of murine LMTK- cells with purified HLA class I genes. III. Human HLA class I antigens coded by hybrid genes constructed in vitro indicate association of serologic reactivities with the first two domains of the molecule. Immunogenetics 18:165-171
4. Kotsch K, Wehling J, Kohler S, Blasczyk R (1997) Sequencing of HLA class I genes based on the conserved diversity of the noncoding regions: sequencing-based typing of the HLA-A gene. Tissue Antigens 50:178-191
5. Lienert K, Russ G, Lester S, Bennett G, Gao X, McCluskey J (1996) Stable inheritance of an HLA-"blank" phenotype associated with a structural mutation in the HLA-A*0301 gene. Tissue Antigens 48:187-191
6. Malissen M, Malissen B, Jordan BR (1982) Exon/intron organization and complete nucleotide sequence of an HLA gene. Proc Natl Acad Sci USA 79:893-897
7. Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Geraghty DE, Hansen JA, Hurley CK, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI, Trowsdale J (2005) Nomenclature for factors of the HLA system, 2004. Tissue Antigens 65:301-369
8. Miyazaki J, Appella E, Ozato K (1986) Intracellular transport blockade caused by disruption of the disulfide bridge in the third external domain of major histocompatibility complex class I antigen. Proc Natl Acad Sci USA 83:757-761
9. Saper MA, Bjorkman PJ, Wiley DC (1991) Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. J Mol Biol 219:277-319
10. Shiroishi T, Evans GA, Appella E, Ozato K (1984) Role of a disulfide bridge in the immune function of major histocompatibility class I antigen as studied by in vitro mutagenesis. Proc Natl Acad Sci USA 81:7544-7548
11. Warburton RJ, Matsui M, Rowland-Jones SL, Gammon MC, Katzenstein GE, Wei T, Edidin M, Zweerink HJ, McMichael AJ, Frelinger JA (1994) Mutation of the alpha 2 domain disulfide bridge of the class I molecule HLA-A*0201. Effect on maturation and peptide presentation. Hum Immunol 39:261-271
12. Zeff RA, Gopas J, Steinhauer E, Rajan TV, Nathenson SG (1986) Analysis of somatic cell H-2 variants to define the structural requirements for class I antigen expression. J Immunol 137:897-903
13. Zeff RA, Nakagawa M, Mashimo H, Gopas J, Nathenson SG (1990) Failure of cell surface expression of a class I major histocompatibility antigen caused by somatic point mutation. Transplantation 49:803-808